ComplianceOnline

FDA Issues Final Guidance on the Use of Electronic Informed Consent

  • By: Staff Editor
  • Date: April 10, 2017
  • Source: http://www.fda.gov
Access Regulatory Compliance Training sessions led by expert panelists below.

Compliance Webinars | Virtual Seminars for Professionals

FDA Issues Final Guidance on the Use of Electronic Informed Consent

The informed consent process has been an area of debate over the past few years. Regulations and guidelines controlling the conduct of clinical trials require informed consent to be obtained from each study subject prior to initiation of clinical investigation. In December 2016, FDA published its final guidance on the use of electronic informed consent. This guidance document finalizes the draft guidance entitled “Use of Electronic Informed Consent in Clinical Investigations--Questions and Answers” published in March 2015.

The final guidance applies to stakeholders in clinical research community including institutional review boards (IRBs), investigators, sponsors and potential trail human subjects. The document provides guidelines on the use of electronic systems that may possibly involve multiple electronic media to obtain informed consent for both HHS and FDA regulated clinical investigations.


Related Training:

Recruitment and Informed Consent: The Cornerstone of Ethical Clinical Research

Ensuring Legally-Effective Informed Consent


Key Focus Areas

The guidance document provide summary of requirements in question and answer format. Some of the key questions addressed in the guidance include:

  • How should information in the electronic informed consent (eIC) be presented to the subject?
  • How and where may the eIC process be conducted?
  • How and when should questions from subjects be answered?
  • What steps may be taken to facilitate the subject’s understanding of the information being presented?
  • How can electronic signatures be used to document eIC?
  • What special considerations should be given to the use of eIC for pediatric studies?
  • What steps can be taken to help ensure privacy, security, and confidentiality of the eIC information?
  • What are the IRB’s responsibilities in the eIC process?

This guidance has addressed these questions and many more to ensure clarity in adhering to the electronic informed consent requirements.

Click here to download the file

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
On Demand Access Anytime
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading